부산대학교 도서관

Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escrivá-de-Romaní S; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Pernas S; SOLTI Cancer Research Group, Barcelona, Spain; Institut Catala d'Oncologia-IDIBELL, L'Hospitalet, Barcelona, Spain.; Paré L; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Adamo B; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez E; Department of Medical Oncology, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Castellón, Spain.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Perelló A; Department of Medical Oncology, Hospital Son Espases, Palma, Spain.; Galan M; Department of Medical Oncology, Hospital Son Llàtzer, Palma, Spain.; Melé M; Department of Medical Oncology, Hospital Sant Joan, Reus, Spain.; Villanueva L; SOLTI Cancer Research Group, Barcelona, Spain.; Gonzalez-Rodriguez M; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Tolosa P; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; González-Farré B; Department of Pathology, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Canes J; SOLTI Cancer Research Group, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona, Spain.; González-Farré X; SOLTI Cancer Research Group, Barcelona, Spain; Institut Oncològic Dr. Rosell, Barcelona, Spain; Hospital General de Catalunya, Sant Cugat del Vallès, Barcelona, Spain; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.; Villagrasa P; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Prat A; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Ciruelos E; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Medical Oncology Department, HM Hospitales, Madrid, Spain. Electronic address: eva.ciruelos@gmail.com.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Sanfeliu, Esther; Brasó-Maristany, Fara; Adamo, Barbara; Pascual, Tomás; Chic, Nuria; Guarneri, Valentina; Parker, Joel S; Griguolo, Gaia; Schettini, Francesco; Marín-Aguilera, Mercedes; Vidal, Maria; Maues, Julia; Paré, Laia; Vivancos, Ana; Angelats, Laura; Conte, Benedetta; Prat, Aleix; Giarratano, Tommaso; Miglietta, Federica; González, Blanca; Martínez-Sáez, Olga; Muñoz, Montserrat; Conte, PierFranco; Dieci, Maria Vittoria; Galván, Patricia; Perou, Charles M; Villagrasa, Patricia

Articles publicats en revistes (Medicina)
Dipòsit Digital de la UB
instname
JNCI: Journal of the National Cancer Institute

Fernandez-Rozadilla, C; Cazier, J B; Moreno, V; Crous-Bou, M; Guinó, E; Durán, G; Lamas, M J; López, R; Candamio, S; Gallardo, E; Paré, L; Baiget, M; Páez, D; López-Fernández, L A; Cortejoso, L; García, M I; Bujanda, L; González, D; Gonzalo, V; Rodrigo, L

Pharmacogenomics Journal. Jun2013, Vol. 13 Issue 3, p209-217. 9p. 6 Charts, 1 Graph.

Marcuello, E.; Páez, D.; Paré, L.; Salazar, J.; Sebio, A.; del Rio, E.; Baiget, M.; Páez, D; Paré, L

British Journal of Cancer. 6/20/2011, Vol. 105 Issue 1, p53-57. 5p. 5 Charts.

Paré, L.; Marcuello, E.; Altés, A.; Del Río, E.; Sedano, L.; Salazar, J.; Cortés, A.; Barnadas, A.; Baiget, M.; Paré, L; Altés, A; del Río, E; Cortés, A

British Journal of Cancer. 9/22/2008, Vol. 99 Issue 7, p1050-1055. 6p. 3 Charts, 2 Graphs.

Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Tapia M; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.; Hernández-Illán E; Core Molecular Laboratory, Hospital Clinic of Barcelona, Barcelona, Spain.; Tébar C; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Martinez-Puchol AI; Core Molecular Laboratory, Hospital Clinic of Barcelona, Barcelona, Spain.; Jares P; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Marín-Liébana S; Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain.; Magro A; Medical Oncology Department, Hospital Comarcal Francesc de Borja, Gandia, Spain.; Puig-Butille JA; Core Molecular Laboratory, Hospital Clinic of Barcelona, Barcelona, Spain.; Palomar L; Medical Oncology Department, Hospital de Sagunto, Sagunto, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Martinez MT; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Losada MV; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Hernando C; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Iranzo V; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain.; Medicine Department, Universitat de València, Valencia, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Pouptsis A; Medical Oncology Department, Hospital Universitario de la Ribera, Alzira, Spain.; Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Santaballa A; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Torregrosa MD; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Gómez-Bravo R; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Burgués O; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Pathology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Fructuoso IG; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Garrido-Cano I; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Seguí E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Carcelero E; Pharmacy Department, Hospital Clinic Barcelona, Barcelona, Spain.; Sànchez J; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Villagrasa-González P; Reveal Genomics, Barcelona, Spain.; Buckingham W; Reveal Genomics, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain.; Villacampa G; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Chic N; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.; Rivera P; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Rezqallah A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Saura C; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escrivà S; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Bermejo B; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Lluch A; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.; Llombart A; Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain.; Cejalvo JM; Medical Oncology Department, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8201 (Electronic) Linking ISSN: 29498201 NLM ISO Abbreviation: ESMO Real World Data Digit Oncol Subsets: PubMed not MEDLINE

Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA. Electronic address: Filipa_Lynce@dfci.harvard.edu.; Martínez-Sáez O; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Walbaum B; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Villacampa Javierre G; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; Sanfeliu E; Pathology Department, Hospital Clinic, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Anderson LM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Parker JS; Life Edit Therapeutics, Morrisville, USA.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; DiLullo MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA.; Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain.; Winer EP; Yale Cancer Center, New Haven, USA.; Overmoyer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.; Mittendorf EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, USA.; Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica H.U. Puerta de Hierro, Majadahonda, Madrid, Spain.; Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.; Prat A; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.; Stecklein SR; Department of Internal Medicine, University of Kansas Medical Center, Westwood; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, USA; Departments of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA; Departments of Cancer Biology, University of Kansas Medical Center, Kansas City, USA.; Gluz O; West German Study Group, Monchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Clinics Cologne, Cologne, Germany.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Nitz U; West German Study Group, Monchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany.; Cobo S; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Christgen M; University Clinics Cologne, Cologne, Germany.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Álvarez EL; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Kuemmel S; Medical School Hannover, Institute of Pathology, Hannover; Breast Unit, Clinics Essen Mitte, Breast Center, Essen, Germany.; Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Madrid, Spain.; Jerez Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Kates R; West German Study Group, Monchengladbach, Germany.; Cebollero M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Kolberg-Liedtke C; Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany.; Bueno O; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; García-Saenz JÁ; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain; Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Moreno F; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain; Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain.; Grischke EM; Department of Gynecology, Women's Clinic, University Clinics Tuebingen, Tuebingen, Germany.; Forstbauer H; Practice Network Troisdorf, Troisdorf, Germany.; Braun M; Breast Center, Rotkreuz Clinics Munich, Munich, Germany.; Warm M; Breast Center, City Hospital Holweide, Cologne, Germany.; Hackmann J; Breast Center, Marien-Hospital, Witten, Germany.; Uleer C; Practice of Gynecology and Oncology, Hildesheim, Germany.; Aktas B; Women's Clinic, University Clinics Essen, Essen, Germany.; Schumacher C; Breast Center, St. Elisabeth Hospital, Cologne, Germany.; Wuerstleins R; West German Study Group, Monchengladbach, Germany; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.; Graeser M; West German Study Group, Monchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Zu Eulenburg C; West German Study Group, Monchengladbach, Germany; University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Kreipe HH; West German Study Group, Monchengladbach, Germany.; Gómez H; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Herrero B; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Bohn U; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain.; López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.; Vivancos A; Reveal Genomics, Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Sharma P; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, USA.; Harbeck N; West German Study Group, Monchengladbach, Germany; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Angelats L; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Rubio-Perez C; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.; González A; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain; Immunogenetics and Immunotherapy in Autoinflammatory and Immune Responses, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Seguí E; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Villacampa G; Statistics Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.; Pernas S; Institut Catala d'Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Institut Català d'Oncologia Medical Oncology, Breast Unit Barcelona, Barcelona, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Albarrán-Fernández V; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Aguirre Á; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Fernandez-Martinez A; Department of Genetics, University of North Carolina, Chapel Hill, USA.; Cobo S; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Rey M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Martínez-Romero A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Buckingham W; Reveal Genomics, Barcelona, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Agrawal Y; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Guedan S; Cellular Immunotherapies for Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; SOLTI Cancer Cooperative Group, Barcelona, Spain.; Agudo J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA; Department of Immunology, Harvard Medical School, Boston, USA; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, USA; New York Stem Cell Foundation, Robertson Investigator, New York, USA.; Grzelak M; Omniscope Inc., Palo Alto, USA.; Borcherding N; Omniscope Inc., Palo Alto, USA.; Heyn H; Omniscope Inc., Palo Alto, USA.; Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Cancer Genomics Group, Barcelona, Spain.; Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Perou CM; Department of Genetics, University of North Carolina, Chapel Hill, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain. Electronic address: FBRASO@recerca.clinic.cat.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Tomás Pascual; Aranzazu Fernandez-Martinez; Maki Tanioka; M. Vittoria Dieci; Sonia Pernas; Joaquin Gavila; Valentina Guarneri; Javier Cortes; Patricia Villagrasa; Núria Chic; Maria Vidal; Barbara Adamo; Montserrat Muñoz; Gaia Griguolo; Antonio Llombart; Pierfranco Conte; Mafalda Oliveira; Benedetta Conte; Laia Paré; Patricia Galvan; Lisa A. Carey; Charles M. Perou; Aleix Prat

CLINICAL CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname

Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P

LANCET ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
The Lancet. Oncology

Guarneri, V; Dieci, M V; Bisagni, G; Frassoldati, A; Bianchi, G V; Salvo, G L De; Orvieto, E; Urso, L; Pascual, T; Paré, L; Galván, P; Ambroggi, M; Giorgi, C A; Moretti, G; Griguolo, G; Vicini, R; Prat, A; Conte, P F

Annals of Oncology. Jun2019, Vol. 30 Issue 6, p921-926. 6p. 2 Charts, 1 Graph.

Paré, L; Pascual, T; Seguí, E; Teixidó, C; Gonzalez-Cao, M; Galván, P; Rodríguez, A; González, B; Cuatrecasas, M; Pineda, E

Annals of Oncology. Oct2018, Vol. 29 Issue 10, p2121-2128. 8p. 2 Graphs.

Cebola, I; Custodio, J; Muñoz, M; Díez-Villanueva, A; Paré, L; Prieto, P; Aussó, S; Coll-Mulet, L; Boscá, L; Moreno, V

CLINICAL EPIGENETICS. 7(1)

Nuciforo, P; Pascual, T; Cortés, J; Llombart-Cussac, A; Fasani, R; Paré, L; Oliveira, M; Galvan, P; Martínez, N; Bermejo, B; Vidal, M; Pernas, S; López, R; Muñoz, M; Garau, I; Manso, L; Alarcón, J; Martínez, E; Rodrik-Outmezguine, V; Brase, J C; Villagrasa, P; Prat, A; Holgado, E

Annals of Oncology. Jan 01, 2018 29(1):170-177

Schettini, Francesco; Garcia-Fructuoso, Isabel; Sanfeliu, Esther; Losada, Maria J. Vidal; Paré, Laia; Chic, Núria; Hernández, Adela Rodríguez; Perou, Charles M.; Parker, Joel S.; Angelats, Laura; Marín-Aguilera, Mercedes; Villagrasa, Patricia; Seguí, Elia; Lorman-Carbó, Natàlia; Conte, Benedetta; Vivancos, Ana; Pascual, Tomás; Prat, Aleix; Martínez-Sáez, Olga; Villacampa, Guillermo; Gómez-Bravo, Raquel; Adamo, Barbara; Brasó-Maristany, Fara; Falato, Claudette; Fratini, Beatrice; Staaf, Johan

eBioMedicine

Marín-Aguilera M; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain.; Jares P; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain.; Sanfeliu E; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain; Statistical Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hernández-Lllán E; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain.; Martínez-Puchol AI; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain.; Shankar S; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; González-Farré B; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Waks AG; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Brasó-Maristany F; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Pardo F; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Manning DK; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Abery JA; Eremid Genomic Services, LLC, Kannapolis, USA.; Curaba J; Eremid Genomic Services, LLC, Kannapolis, USA.; Moon L; Eremid Genomic Services, LLC, Kannapolis, USA.; Gordon O; Eremid Genomic Services, LLC, Kannapolis, USA.; Galván P; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Wachirakantapong P; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Nee CM; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Senevirathne TH; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain; Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Aguirre A; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Krop IE; Yale Cancer Center, New Haven, USA.; Li Z; Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA.; Spellman P; Oregon Health and Science University, Portland, USA.; Metzger Filho O; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA; Harvard Medical School, Boston, USA.; Polyak K; Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA.; Michaels P; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA.; Puig-Butillé JA; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain.; Vivancos A; Cancer Genomics Core, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Matito J; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Cancer Genomics Core, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Buckingham W; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain.; Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Villagrasa-González P; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain.; Prat A; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain; Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Breast Cancer Unit, IOB-Quirón Salud, Barcelona, Spain.; Parker JS; Department of Genetics, Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Paré L; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain. Electronic address: lpare@reveal-genomics.com.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Villacampa G; SOLTI Breast Cancer Research Group, Barcelona; Statistics Unit, Vall d'Hebron Institute of Oncology, Barcelona.; Pascual T; SOLTI Breast Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona.; Paré L; Reveal Genomics, Barcelona.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona.; Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona.; Ciruelos E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid.; Martin M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.; Conte P; San Camillo Hospital, IRCCS, Venezia Lido, Italy.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Fernandez A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Harbeck N; Breast Center, Ludwig Maximilians University-Grosshadern, Munich, Germany.; Marín-Aguilera M; Reveal Genomics, Barcelona.; Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain.; Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Villagrasa P; Reveal Genomics, Barcelona.; Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona; Reveal Genomics, Barcelona.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA. Electronic address: Sara_Tolaney@DFCI.HARVARD.EDU.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Serna G; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Pascual T; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Fasani R; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Guardia X; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Chic N; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Paré L; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Pernas S; Institut Catala d'Oncologia-H.U.Bellvitge-IDIBELL, Hospitalet, Barcelona, Spain.; Muñoz M; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Oliveira M; Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Vidal M; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Llombart-Cussac A; Hospital Universitario Arnau de Vilanova de Valencia, Valencia, Spain.; Cortés J; IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Bermejo B; Hospital Clínico Universitario de Valencia/INCLIVA/CIBERONC, Valencia, Spain.; Martínez N; Hospital Universitario Ramón y Cajal, Madrid, Spain.; López R; Hospital Clínico Universitario de Santiago, IDIS, CIBERONC, Santiago de Compostela, Spain.; Morales S; Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain.; Garau I; Hospital Son Llàtzer, Palma de Mallorca, Spain.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Alarcón J; Hospital Universitario Son Espases, Palma de Mallorca, Spain.; Martínez E; Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain.; Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. alprat@clinic.cat.; SOLTI Breast Cancer Research Group, Barcelona, Spain. alprat@clinic.cat.; Nuciforo P; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain. pnuciforo@vhio.net.; SOLTI Breast Cancer Research Group, Barcelona, Spain. pnuciforo@vhio.net.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Manso, L; Salvador, F; Villagrasa, P; Chic, N; Bermejo, B; Cejalvo, JM; Izarzugaza, Y; Cantos, B; Blanch, S; Margeli, M; Alonso, JL; Martinez, A; Villanueva, R; Guerra, JA; Andres, R; Zamora, P; Nogales, E; Juan, M; Gonzalez-Farre, B; Wilkinson, GA; Heineman, TC; Nuovo, G; Loghmani, H; Coffey, M; Gonzalez, A; Martinez, D; Pare, L; Pascual, T; Gonzalez, X; Prat, A; Gavila, J

Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)